Latest Nanobodies Stories
Creating a radioactive antibody fragment may allow scientists to identify fat and debris deposits in artery walls that are most likely to rupture and cause heart attacks.
Nanobodies produced by camels have unique properties, which can be used in future drug development.
Scientists at the Southwest Foundation for Biomedical Research (SFBR) have for the first time developed a highly sensitive means of detecting the seven types of botulinum neurotoxins (BoNTs) simultaneously.
NEW YORK, Oct.
Reportlinker.com announces that a new market research report related to the Pharmaceutical industry is available in its catalogue.
Ablynx, a biopharmaceutical company focused on the discovery and development of nanobodies, has received a grant worth E1.8 million from the Institute for the Promotion of Innovation by Science and Technology in Flanders.
The head of biotech research GlaxoSmithKline Plc said a new generation of "slimline" antibody medicines may be successors to current blockbusters such as Avastin and Rituxan.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, has entered into an agreement with Ablynx, to co-discover and co-develop Nanobodies against two targets in oncology and immunology. The agreement includes an upfront cash payment to Ablynx of E10 million.
Ablynx and Merck Serono to equally contribute to discover and develop Nanobodies(R) against two targets in oncology and immunology and equally share the resulting profits Ghent, BELGIUM, 4 September 2008 - Ablynx [Euronext Brussels: ABLX], a pioneer in the discovery and development of Nanobodies(R), a novel class of antibody-derived therapeutic proteins, today announced that it has entered into an agreement with Merck Serono, a division of Merck KGaA, Darmstadt, Germany, to...